Search Results 31-40 of 23927 for pharmacogenetics
One part of pharmacogenetic testing looks at the ... The study included 3016 patients who had undergone pharmacogenetics testing between 2003 and 2013.
The Psychiatric Genomics and Pharmacogenomics Program at Mayo Clinic studies links between genetics, bipolar disorder, addiction and alcohol use disorder to ...
Efforts to identify response biomarkers through the application of multiple omics including genomics, transcriptomics, epigenomics, metabolomics and ...
The study of genetic polymorphisms associated with gastrointestinal traits and obesity therapy, known as pharmacogenetics and novel pharmacotherapeutics, are a ...
Pharmacogenetics and pharmacogenomics. Use cutting-edge genetic technologies to discover, at the molecular and cellular levels, why humans have vastly ...
The Experimental Therapeutics Program of Mayo Clinic Comprehensive Cancer Center researches anti-cancer therapies, early-phase trials, pharmacogenetics and ...
... Pharmacogenetics Working Group. 2017 - present. MemberClinical Immunology Society. 2016 - present. MemberClinical Pharmacogenetics Implementation Consortium ( ...
After nearly half a century of research, Mayo Clinic is a leader in moving pharmacogenomics into clinical practice. This year pharmacogenomics test results ...
Goetz's focus has been the pharmacogenetics of tamoxifen. Out of this work, and in collaboration with the Developmental Therapeutics Program of the National ...
Now using pharmacogenomics testing, which looks at how a person's genetic traits affect their medication response, and a new gene verifier model, Dr. Diasio and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.